BioSpace News Archive

Business

Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 17, 2022

Organon (NYSE: OGN), will release its fourth quarter and full year 2021 financial results on February 17, 2022, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.

February 1, 2022

·

2 min read

Drug Development

Arcutis Completes Enrollment of STRATUM Pivotal Phase 3 Trial of Topical Roflumilast Foam in Individuals with Seborrheic Dermatitis

Arcutis Biotherapeutics, Inc. today announced the enrollment of the last subject its STRATUM phase 3 pivotal trial for topical roflumilast foam in patients with seborrheic dermatitis.

February 1, 2022

·

5 min read

Business

Sarepta Therapeutics and GenEdit Share Progress on Research Collaboration and Announce Agreement to Develop Gene Editing Therapeutics for Neuromuscular Diseases

Sarepta and GenEdit will work together to identify development candidates for further testing.

February 1, 2022

·

7 min read

Biotech Bay

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex® Technology and Intervention

ImpediMed Limited announced publication of results from the PREVENT trial showing that fewer breast cancer patients with early detection using L-Dex and intervention progressed to chronic lymphedema when compared to patients monitored with tape measure, which is the current standard of care.

February 1, 2022

·

7 min read

Business

Seagen Appoints Lee Heeson as Executive Vice President, Commercial International

Seagen Inc. (Nasdaq:SGEN) today announced the appointment of Lee Heeson as Executive Vice President, Commercial International.

February 1, 2022

·

3 min read

Pharm Country

Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture

Halberd Corporation (OTC PINK:HALB) has demonstrated the ability to selectively reduce and control the level of one element in a heterogeneous mixture containing two elements without affecting the levels of the second element.

February 1, 2022

·

3 min read

Genetown

Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR® Therapeutic Procedure in Patients with Type 2 Diabetes

Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes, announced the publication of two-year durability data from its REVITA-1 clinical study conducted at centers in Europe and South America.

February 1, 2022

·

6 min read

Genetown

Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA® Blood Test

Scipher Medicine Announces Publication of Real-World Study Demonstrating Clinical Utility of PrismRA ® Blood Test.

February 1, 2022

·

4 min read

Business

Cortexyme Announces Change in Executive Leadership Team

Cortexyme, Inc. today announced that its board of directors has appointed Christopher Lowe, the company’s chief operating officer and chief financial officer, as interim chief executive.

February 1, 2022

·

5 min read

Biotech Bay

AcelRx Pharmaceuticals Announces Publication of Clinical Data on the Use of Sufentanil Sublingual Tablet during Awake Plastic Surgery Procedures

AcelRx Pharmaceuticals, Inc.today announced the publication of real-world data in patients undergoing awake plastic surgery showing a rapid recovery time and minimal side effects with the use of sufentanil sublingual tablet (SST) for pain management.

February 1, 2022

·

5 min read